BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 35055057)

  • 21. Potentiality of Exosomal Proteins as Novel Cancer Biomarkers for Liquid Biopsy.
    Hu C; Jiang W; Lv M; Fan S; Lu Y; Wu Q; Pi J
    Front Immunol; 2022; 13():792046. PubMed ID: 35757760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging role of exosomes as biomarkers in cancer treatment and diagnosis.
    Hanjani NA; Esmaelizad N; Zanganeh S; Gharavi AT; Heidarizadeh P; Radfar M; Omidi F; MacLoughlin R; Doroudian M
    Crit Rev Oncol Hematol; 2022 Jan; 169():103565. PubMed ID: 34871719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid Biopsy: Is There an Advantage to Analyzing Circulating Exosomal DNA Compared to cfDNA or Are They the Same?
    Kahlert C
    Cancer Res; 2019 May; 79(10):2462-2465. PubMed ID: 31043377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquid Biopsy: A New Tool in Oncology.
    Costa JL; Schmitt FC
    Acta Cytol; 2019; 63(6):448. PubMed ID: 31266005
    [No Abstract]   [Full Text] [Related]  

  • 25. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
    Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
    Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
    [No Abstract]   [Full Text] [Related]  

  • 26. Recent advances in the applications of DNA frameworks in liquid biopsy: A review.
    Duan X; Qin W; Hao J; Yu X
    Anal Chim Acta; 2024 Jun; 1308():342578. PubMed ID: 38740462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep cfDNA fragment end profiling enables cancer detection.
    Zhitnyuk YV; Koval AP; Alferov AA; Shtykova YA; Mamedov IZ; Kushlinskii NE; Chudakov DM; Shcherbo DS
    Mol Cancer; 2022 Jan; 21(1):26. PubMed ID: 35062943
    [No Abstract]   [Full Text] [Related]  

  • 28. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
    Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
    Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of liquid biopsy in bone and soft tissue sarcomas: Present and future.
    Li X; Seebacher NA; Hornicek FJ; Xiao T; Duan Z
    Cancer Lett; 2018 Dec; 439():66-77. PubMed ID: 30223067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Label-free characterization of exosome via surface enhanced Raman spectroscopy for the early detection of pancreatic cancer.
    Carmicheal J; Hayashi C; Huang X; Liu L; Lu Y; Krasnoslobodtsev A; Lushnikov A; Kshirsagar PG; Patel A; Jain M; Lyubchenko YL; Lu Y; Batra SK; Kaur S
    Nanomedicine; 2019 Feb; 16():88-96. PubMed ID: 30550805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer.
    Hofmann L; Ludwig S; Vahl JM; Brunner C; Hoffmann TK; Theodoraki MN
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liquid Biopsy: General Concepts.
    Poulet G; Massias J; Taly V
    Acta Cytol; 2019; 63(6):449-455. PubMed ID: 31091522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimeric RNA and Exosomes-Based Liquid Biopsy.
    Ke X; Xiong X; Lin Y; Zhang H
    Methods Mol Biol; 2020; 2079():211-218. PubMed ID: 31728973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomes as a new frontier of cancer liquid biopsy.
    Yu D; Li Y; Wang M; Gu J; Xu W; Cai H; Fang X; Zhang X
    Mol Cancer; 2022 Feb; 21(1):56. PubMed ID: 35180868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The biology and function of exosomes in cancer.
    Kalluri R
    J Clin Invest; 2016 Apr; 126(4):1208-15. PubMed ID: 27035812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The decade of exosomal long RNA species: an emerging cancer antagonist.
    Zhou R; Chen KK; Zhang J; Xiao B; Huang Z; Ju C; Sun J; Zhang F; Lv XB; Huang G
    Mol Cancer; 2018 Mar; 17(1):75. PubMed ID: 29558960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics.
    Geeurickx E; Hendrix A
    Mol Aspects Med; 2020 Apr; 72():100828. PubMed ID: 31711714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in nanotechnology-enabled biosensors for detection of exosomes as new cancer liquid biopsy.
    Hsu CC; Wu Y
    Exp Biol Med (Maywood); 2022 Dec; 247(23):2152-2172. PubMed ID: 35938477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular vesicles compartment in liquid biopsies: Clinical application.
    Garcia-Romero N; Esteban-Rubio S; Rackov G; Carrión-Navarro J; Belda-Iniesta C; Ayuso-Sacido A
    Mol Aspects Med; 2018 Apr; 60():27-37. PubMed ID: 29155161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomes as a liquid biopsy for lung cancer.
    Cui S; Cheng Z; Qin W; Jiang L
    Lung Cancer; 2018 Feb; 116():46-54. PubMed ID: 29413050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.